FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards

Nov.06.2024
FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
The new Fumot Tornado 4-in-1 e-cigarette from FUMOT is now available on UK sites like Vapesourcing and Powervapeshop. The product complies with EU TPD standards and offers approximately 4,000 puffs.

Recently, 2Firsts noted that FUMOT's new 4-in-1 product, the Fumot Tornado 4in1, has been listed on the brand's official website as well as on UK e-cigarette distributor sites like Vapesourcing and Powervapeshop. The product complies with TPD standards and offers approximately 4,000 puffs.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Fumot Tornado 4in1 | Image source: vapesourcing

 

Specifically, the features of the Fumot Tornado 4in1 include:

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Mapping: 2Firsts

 

At the InterTabac tobacco exhibition held in September, the FUMOT brand was interviewed by the 2Firsts team. Brand representatives said, "New large disposable products that meet TPD standards are emerging," and emphasized the importance of actively complying with regulatory standards for long-term stability. The brand also launched several innovative products, such as "2+10," at the exhibition to meet the demands of the German market.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
FUMOT brand products are listed on the vapesourcing website|Image source: vapesourcing

 

According to observations by 2Firsts, websites that offer online sales of FUMOT e-cigarettes in the UK are relatively limited. FUMOT products were not found on popular sites such as VapeUK, VapeClub, eCigaretteDirect, and ZeroVapes. However, on sites like Vapesourcing and PowerVapeShop, where FUMOT products are available, the offerings mainly consist of high-puff disposable e-cigarettes.

 

In a review article on the Fumot Tornado 4in1 by the e-cigarette website *Planet of the Vapes*, it was noted: “They [referring to the FUMOT brand] have many devices that do not comply with TPD (Tobacco Products Directive) regulations, but also a few that do, which is why their business is global.”

 

“Some of the flavors [of the Fumot Tornado 4in1] are indeed well-blended.”

 

“Since they are 4-in-1, you might find a flavor in the pack you purchase that you don’t enjoy.”

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Review article of the Fumot Tornado 4in1 released by planetofthevapes|Image source planetofthevapes

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Review article of Fumot Tornado 4in1 published by Planet of the Vapes | Image source: Planet of the Vapes

 

It is worth noting that on FUMOT’s official website, a separate “TPD Series” section is listed under the product category, featuring products compliant with TPD standards. This series includes low-puff disposables, open systems, refillable models, and 4-in-1 multi-flavor devices.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
FUMOT official website TPD Series | Image source: FUMOT official website

 

2Firsts will continue to monitor the latest e-cigarette products and market trends globally, providing the public with accurate and authoritative industry information.

 


 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece Oppose Ireland’s Nicotine Product Bill, Raising EU Regulatory Concerns
Italy and Greece have opposed Ireland’s proposed nicotine product regulations, arguing that the measures could affect EU market coordination and the free movement of products. Ireland plans to introduce stricter rules covering nicotine products including vapes and nicotine pouches, with measures involving packaging, marketing and sales controls. The dispute highlights differences among EU member states between stronger public health protections and maintaining regulatory consistency within the bloc’s single market.
Jul.29
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
At InterTabac 2026 in Dortmund, China Tobacco International (HK) Company Limited (CTIHK) is exhibiting across two separate booths in Hall 5 and Hall 4. Products observed by 2Firsts include heated tobacco products, nicotine pouches, Chinese cigars and tobacco leaf. Nicotine pouch products on display include TOOP, Shuangxi and Ashima.
Market
Sep.16
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14